AIDX is 20/20 Biolabs, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.63. Market cap: $8M.
Stock snapshot
| Price | $0.63 |
| Market cap | $8M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About AIDX
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Related non-dividend companies
Other non-dividend stocks investors research alongside AIDX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is AIDX's current stock price?
AIDX (20/20 Biolabs, Inc.) is currently trading at $0.63.
Does AIDX pay a dividend?
AIDX (20/20 Biolabs, Inc.) does not currently pay a regular dividend.
Track AIDX in DiviDrip
Add AIDX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search AIDX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.